<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36927795</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1478-6362</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>16</Day></PubDate></JournalIssue><Title>Arthritis research &amp; therapy</Title><ISOAbbreviation>Arthritis Res Ther</ISOAbbreviation></Journal><ArticleTitle>Fecal microbiota from MRL/lpr mice exacerbates pristane-induced lupus.</ArticleTitle><Pagination><StartPage>42</StartPage><MedlinePgn>42</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">42</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13075-023-03022-w</ELocationID><Abstract><AbstractText Label="BACKGROUND">The roles of gut microbiota in the pathogenesis of SLE have been receiving much attention during recent years. However, it remains unknown how fecal microbiota transplantation (FMT) and microbial metabolites affect immune responses and lupus progression.</AbstractText><AbstractText Label="METHODS">We transferred fecal microbiota from MRL/lpr (Lpr) mice and MRL/Mpj (Mpj) mice or PBS to pristane-induced lupus mice and observed disease development. We also screened gut microbiota and metabolite spectrums of pristane-induced lupus mice with FMT via 16S rRNA sequencing, metagenomic sequencing, and metabolomics, followed by correlation analysis.</AbstractText><AbstractText Label="RESULTS">FMT from MRL/lpr mice promoted the pathogenesis of pristane-induced lupus and affected immune cell profiles in the intestine, particularly the plasma cells. The structure and composition of microbial communities in the gut of the FMT-Lpr mice were different from those of the FMT-Mpj mice and FMT-PBS mice. The abundances of specific microbes such as prevotella taxa were predominantly elevated in the gut microbiome of the FMT-Lpr mice, which were positively associated with functional pathways such as cyanoamino acid metabolism. Differential metabolites such as valine and L-isoleucine were identified with varied abundances among the three groups. The abundance alterations of the prevotella taxa may affect the phenotypic changes such as proteinuria levels in the pristane-induced lupus mice.</AbstractText><AbstractText Label="CONCLUSION">These findings further confirm that gut microbiota play an important role in the pathogenesis of lupus. Thus, altering the gut microbiome may provide a novel way to treat lupus.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Xiaoqing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Key Technologies of Diagnosis and Treatment for Immune-related Skin Diseases, Chinese Academy of Medical Sciences, Changsha, 410011, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Medical Research Center of Major Skin Diseases and Skin Health of Hunan Province, Changsha, 410011, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Medical Epigenomics, Second Xiangya Hospital, , Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Cancan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Key Technologies of Diagnosis and Treatment for Immune-related Skin Diseases, Chinese Academy of Medical Sciences, Changsha, 410011, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Medical Research Center of Major Skin Diseases and Skin Health of Hunan Province, Changsha, 410011, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Medical Epigenomics, Second Xiangya Hospital, , Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chuyi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Key Technologies of Diagnosis and Treatment for Immune-related Skin Diseases, Chinese Academy of Medical Sciences, Changsha, 410011, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Medical Research Center of Major Skin Diseases and Skin Health of Hunan Province, Changsha, 410011, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Medical Epigenomics, Second Xiangya Hospital, , Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha, 410011, China. zhaoming307@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit of Key Technologies of Diagnosis and Treatment for Immune-related Skin Diseases, Chinese Academy of Medical Sciences, Changsha, 410011, China. zhaoming307@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Medical Research Center of Major Skin Diseases and Skin Health of Hunan Province, Changsha, 410011, China. zhaoming307@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Medical Epigenomics, Second Xiangya Hospital, , Central South University, Changsha, 410011, China. zhaoming307@csu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Qianjin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Hunan Key Laboratory of Medical Epigenomics, Second Xiangya Hospital, , Central South University, Changsha, 410011, China. qianlu5860@pumcderm.cams.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China. qianlu5860@pumcderm.cams.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, China. qianlu5860@pumcderm.cams.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, China. qianlu5860@pumcderm.cams.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arthritis Res Ther</MedlineTA><NlmUniqueID>101154438</NlmUniqueID><ISSNLinking>1478-6354</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>26HZV48DT1</RegistryNumber><NameOfSubstance UI="C009042">pristane</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012336">RNA, Ribosomal, 16S</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019463" MajorTopicYN="N">Mice, Inbred MRL lpr</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012336" MajorTopicYN="N">RNA, Ribosomal, 16S</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="Y">Microbiota</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">L-Isoleucine</Keyword><Keyword MajorTopicYN="N">MRL/lpr</Keyword><Keyword MajorTopicYN="N">Metabolomics</Keyword><Keyword MajorTopicYN="N">Metagenomic sequencing</Keyword><Keyword MajorTopicYN="N">Microbiota</Keyword><Keyword MajorTopicYN="N">Prevotella</Keyword><Keyword MajorTopicYN="N">SLE</Keyword><Keyword MajorTopicYN="N">Valine</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>17</Day><Hour>8</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36927795</ArticleId><ArticleId IdType="pmc">PMC10018936</ArticleId><ArticleId IdType="doi">10.1186/s13075-023-03022-w</ArticleId><ArticleId IdType="pii">10.1186/s13075-023-03022-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun. 2019;96:1&#x2013;13. doi: 10.1016/j.jaut.2018.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.11.001</ArticleId><ArticleId IdType="pmc">PMC6310637</ArticleId><ArticleId IdType="pubmed">30448290</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Qing P, Yang H, Wu Y, Liu Y, Luo Y. Gut microbiome and metabolites in systemic lupus erythematosus: link, mechanisms and intervention. Front Immunol. 2021;12:686501. doi: 10.3389/fimmu.2021.686501.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686501</ArticleId><ArticleId IdType="pmc">PMC8319742</ArticleId><ArticleId IdType="pubmed">34335588</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Yi X, Long H, Zhang G, Wu H, Zhao M, Lu Q. Disordered cutaneous microbiota in systemic lupus erythematosus. J Autoimmun. 2020;108:102391. doi: 10.1016/j.jaut.2019.102391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102391</ArticleId><ArticleId IdType="pubmed">31883828</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Meulen TA, Harmsen HJM, Vila AV, Kurilshikov A, Liefers SC, Zhernakova A, Fu J, Wijmenga C, Weersma RK, de Leeuw K, et al. Shared gut, but distinct oral microbiota composition in primary Sjogren's syndrome and systemic lupus erythematosus. J Autoimmun. 2019;97:77&#x2013;87. doi: 10.1016/j.jaut.2018.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.10.009</ArticleId><ArticleId IdType="pubmed">30416033</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzouz D, Omarbekova A, Heguy A, Schwudke D, Gisch N, Rovin BH, Caricchio R, Buyon JP, Alekseyenko AV, Silverman GJ. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis. 2019;78(7):947&#x2013;956. doi: 10.1136/annrheumdis-2018-214856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-214856</ArticleId><ArticleId IdType="pmc">PMC6585303</ArticleId><ArticleId IdType="pubmed">30782585</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Q, Zhang H, Liao X, Lin K, Liu H, Edwards MR, Ahmed SA, Yuan R, Li L, Cecere TE, et al. Control of lupus nephritis by changes of gut microbiota. Microbiome. 2017;5(1):73. doi: 10.1186/s40168-017-0300-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-017-0300-8</ArticleId><ArticleId IdType="pmc">PMC5505136</ArticleId><ArticleId IdType="pubmed">28697806</ArticleId></ArticleIdList></Reference><Reference><Citation>Kono DH, Theofilopoulos AN. Genetics of SLE in mice. Springer Semin Immunopathol. 2006;28(2):83&#x2013;96. doi: 10.1007/s00281-006-0030-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-006-0030-7</ArticleId><ArticleId IdType="pubmed">16972052</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978;148(5):1198&#x2013;1215. doi: 10.1084/jem.148.5.1198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.148.5.1198</ArticleId><ArticleId IdType="pmc">PMC2185049</ArticleId><ArticleId IdType="pubmed">309911</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabs DA, Kuppers RC, Saboori AM, Burek CL, Enger C, Lee B, Prendergast RA. Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/MP-lpr/lpr mice. Cell Immunol. 1994;154(1):66&#x2013;76. doi: 10.1006/cimm.1994.1057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/cimm.1994.1057</ArticleId><ArticleId IdType="pubmed">7907009</ArticleId></ArticleIdList></Reference><Reference><Citation>Shlomchik MJ, Madaio MP, Ni D, Trounstein M, Huszar D. The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med. 1994;180(4):1295&#x2013;1306. doi: 10.1084/jem.180.4.1295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.180.4.1295</ArticleId><ArticleId IdType="pmc">PMC2191708</ArticleId><ArticleId IdType="pubmed">7931063</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamaguchi Y, Uchida J, Cain DW, Venturi GM, Poe JC, Haas KM, Tedder TF. The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice. J Immunol. 2005;174(7):4389&#x2013;4399. doi: 10.4049/jimmunol.174.7.4389.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.174.7.4389</ArticleId><ArticleId IdType="pubmed">15778404</ArticleId></ArticleIdList></Reference><Reference><Citation>Haraldsson MK, Louis-Dit-Sully CA, Lawson BR, Sternik G, Santiago-Raber ML, Gascoigne NR, Theofilopoulos AN, Kono DH. The lupus-related Lmb3 locus contains a disease-suppressing Coronin-1A gene mutation. Immunity. 2008;28(1):40&#x2013;51. doi: 10.1016/j.immuni.2007.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2007.11.023</ArticleId><ArticleId IdType="pmc">PMC2274909</ArticleId><ArticleId IdType="pubmed">18199416</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Liao X, Sparks JB, Luo XM. Dynamics of gut microbiota in autoimmune lupus. Appl Environ Microbiol. 2014;80(24):7551&#x2013;7560. doi: 10.1128/AEM.02676-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.02676-14</ArticleId><ArticleId IdType="pmc">PMC4249226</ArticleId><ArticleId IdType="pubmed">25261516</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh M, Kumar A, Kanwar YS, Reeves WH. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc Natl Acad Sci U S A. 1995;92(24):10934&#x2013;10938. doi: 10.1073/pnas.92.24.10934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.24.10934</ArticleId><ArticleId IdType="pmc">PMC40545</ArticleId><ArticleId IdType="pubmed">7479913</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh M, Reeves WH. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med. 1994;180(6):2341&#x2013;2346. doi: 10.1084/jem.180.6.2341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.180.6.2341</ArticleId><ArticleId IdType="pmc">PMC2191761</ArticleId><ArticleId IdType="pubmed">7964507</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry D, Sang A, Yin Y, Zheng YY, Morel L. Murine models of systemic lupus erythematosus. J Biomed Biotechnol. 2011;2011:271694. doi: 10.1155/2011/271694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/271694</ArticleId><ArticleId IdType="pmc">PMC3042628</ArticleId><ArticleId IdType="pubmed">21403825</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiyohara H, Sujino T, Teratani T, Miyamoto K, Arai MM, Nomura E, Harada Y, Aoki R, Koda Y, Mikami Y, et al. Toll-like receptor 7 agonist-induced dermatitis causes severe dextran sulfate sodium colitis by altering the gut microbiome and immune cells. Cell Mol Gastroenterol Hepatol. 2019;7(1):135&#x2013;156. doi: 10.1016/j.jcmgh.2018.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmgh.2018.09.010</ArticleId><ArticleId IdType="pmc">PMC6260383</ArticleId><ArticleId IdType="pubmed">30510995</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Tan Y, Peng Q, Huang C, Guo Y, Liang G, Zhu B, Huang Y, Liu A, Wang Z, et al. IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation. Nat Commun. 2018;9(1):583. doi: 10.1038/s41467-018-02890-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-02890-0</ArticleId><ArticleId IdType="pmc">PMC5805701</ArticleId><ArticleId IdType="pubmed">29422534</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34(17):i884&#x2013;i890. doi: 10.1093/bioinformatics/bty560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty560</ArticleId><ArticleId IdType="pmc">PMC6129281</ArticleId><ArticleId IdType="pubmed">30423086</ArticleId></ArticleIdList></Reference><Reference><Citation>Magoc T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 2011;27(21):2957&#x2013;2963. doi: 10.1093/bioinformatics/btr507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btr507</ArticleId><ArticleId IdType="pmc">PMC3198573</ArticleId><ArticleId IdType="pubmed">21903629</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73(16):5261&#x2013;5267. doi: 10.1128/AEM.00062-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.00062-07</ArticleId><ArticleId IdType="pmc">PMC1950982</ArticleId><ArticleId IdType="pubmed">17586664</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng W, Yi P, Yang J, Xu P, Wang Y, Zhang Z, Huang S, Wang Z, Zhang C. Association of gut microbiota composition and function with a senescence-accelerated mouse model of Alzheimer's disease using 16S rRNA gene and metagenomic sequencing analysis. Aging (Albany NY). 2018;10(12):4054&#x2013;4065. doi: 10.18632/aging.101693.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101693</ArticleId><ArticleId IdType="pmc">PMC6326683</ArticleId><ArticleId IdType="pubmed">30562162</ArticleId></ArticleIdList></Reference><Reference><Citation>Noguchi H, Park J, Takagi T. MetaGene: prokaryotic gene finding from environmental genome shotgun sequences. Nucleic Acids Res. 2006;34(19):5623&#x2013;5630. doi: 10.1093/nar/gkl723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkl723</ArticleId><ArticleId IdType="pmc">PMC1636498</ArticleId><ArticleId IdType="pubmed">17028096</ArticleId></ArticleIdList></Reference><Reference><Citation>Hevia A, Milani C, Lopez P, Cuervo A, Arboleya S, Duranti S, Turroni F, Gonzalez S, Suarez A, Gueimonde M, et al. Intestinal dysbiosis associated with systemic lupus erythematosus. mBio. 2014;5(5):e01548&#x2013;01514. doi: 10.1128/mBio.01548-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01548-14</ArticleId><ArticleId IdType="pmc">PMC4196225</ArticleId><ArticleId IdType="pubmed">25271284</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z, Shao T, Li H, Xie Z, Wen C. Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus. Gut Pathog. 2016;8:64. doi: 10.1186/s13099-016-0146-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13099-016-0146-9</ArticleId><ArticleId IdType="pmc">PMC5146896</ArticleId><ArticleId IdType="pubmed">27980687</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017;151(4):363&#x2013;374. doi: 10.1111/imm.12760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12760</ArticleId><ArticleId IdType="pmc">PMC5506432</ArticleId><ArticleId IdType="pubmed">28542929</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda Y, Kurakawa T, Umemoto E, Motooka D, Ito Y, Gotoh K, Hirota K, Matsushita M, Furuta Y, Narazaki M, et al. Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine. Arthritis Rheumatol. 2016;68(11):2646&#x2013;2661. doi: 10.1002/art.39783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39783</ArticleId><ArticleId IdType="pubmed">27333153</ArticleId></ArticleIdList></Reference><Reference><Citation>Pianta A, Arvikar S, Strle K, Drouin EE, Wang Q, Costello CE, Steere AC. Evidence of the immune relevance of Prevotella copri, a gut microbe, in patients with rheumatoid arthritis. Arthritis Rheumatol. 2017;69(5):964&#x2013;975. doi: 10.1002/art.40003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40003</ArticleId><ArticleId IdType="pmc">PMC5406252</ArticleId><ArticleId IdType="pubmed">27863183</ArticleId></ArticleIdList></Reference><Reference><Citation>Greiling TM, Dehner C, Chen X, Hughes K, Iniguez AJ, Boccitto M, Ruiz DZ, Renfroe SC, Vieira SM, Ruff WE, et al. Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci Transl Med. 2018;10(434):eaan2306. doi: 10.1126/scitranslmed.aan2306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aan2306</ArticleId><ArticleId IdType="pmc">PMC5918293</ArticleId><ArticleId IdType="pubmed">29593104</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Yin X, Wang H, Wu X, Li X, Li Y, Zhang X, Fu C, Li H, Qiu Y. Fecal metabolomics and potential biomarkers for systemic lupus erythematosus. Front Immunol. 2019;10:976. doi: 10.3389/fimmu.2019.00976.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00976</ArticleId><ArticleId IdType="pmc">PMC6509220</ArticleId><ArticleId IdType="pubmed">31130958</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R, Jiang H, Gu S, Feng N, Zhang N, Lv L, Liu F. Fecal metabolites were altered, identified as biomarkers and correlated with disease activity in patients with systemic lupus erythematosus in a GC-MS-based metabolomics study. Front Immunol. 2020;11:2138. doi: 10.3389/fimmu.2020.02138.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.02138</ArticleId><ArticleId IdType="pmc">PMC7511511</ArticleId><ArticleId IdType="pubmed">33013903</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie C, He T, Zhang W, Zhang G, Ma X. Branched chain amino acids: beyond nutrition metabolism. Int J Mol Sci. 2018;19(4):954. doi: 10.3390/ijms19040954.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19040954</ArticleId><ArticleId IdType="pmc">PMC5979320</ArticleId><ArticleId IdType="pubmed">29570613</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren M, Zhang S, Liu X, Li S, Mao X, Zeng X, Qiao S. Different lipopolysaccharide branched-chain amino acids modulate porcine intestinal endogenous beta-defensin expression through the Sirt1/ERK/90RSK pathway. J Agric Food Chem. 2016;64(17):3371&#x2013;3379. doi: 10.1021/acs.jafc.6b00968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.6b00968</ArticleId><ArticleId IdType="pubmed">27083206</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren M, Zhang SH, Zeng XF, Liu H, Qiao SY. Branched-chain amino acids are beneficial to maintain growth performance and intestinal immune-related function in weaned piglets fed protein restricted diet. Asian-Australas J Anim Sci. 2015;28(12):1742&#x2013;1750. doi: 10.5713/ajas.14.0131.</Citation><ArticleIdList><ArticleId IdType="doi">10.5713/ajas.14.0131</ArticleId><ArticleId IdType="pmc">PMC4647083</ArticleId><ArticleId IdType="pubmed">26580442</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Wang J, He T, Becker S, Zhang G, Li D, Ma X. Butyrate: a double-edged sword for health? Adv Nutr. 2018;9(1):21&#x2013;29. doi: 10.1093/advances/nmx009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmx009</ArticleId><ArticleId IdType="pmc">PMC6333934</ArticleId><ArticleId IdType="pubmed">29438462</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma N, Guo P, Zhang J, He T, Kim SW, Zhang G, Ma X. Nutrients mediate intestinal bacteria-mucosal immune crosstalk. Front Immunol. 2018;9:5. doi: 10.3389/fimmu.2018.00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00005</ArticleId><ArticleId IdType="pmc">PMC5787545</ArticleId><ArticleId IdType="pubmed">29416535</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan P, Li L, Rezaei A, Eslamfam S, Che D, Ma X. Metabolites of dietary protein and peptides by intestinal microbes and their impacts on gut. Curr Protein Pept Sci. 2015;16(7):646&#x2013;654. doi: 10.2174/1389203716666150630133657.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389203716666150630133657</ArticleId><ArticleId IdType="pubmed">26122784</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan B, Huang J, Zhang C, Hu X, Gao M, Shi A, Zha W, Shi L, Huang C, Yang L. Serum metabolomic profiling in patients with systemic lupus erythematosus by GC/MS. Mod Rheumatol. 2016;26(6):914&#x2013;922. doi: 10.3109/14397595.2016.1158895.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/14397595.2016.1158895</ArticleId><ArticleId IdType="pubmed">26915395</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang X, Dai Y, Wen JL, Wang LX. (1)H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus. Lupus. 2011;20(13):1411&#x2013;1420. doi: 10.1177/0961203311418707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203311418707</ArticleId><ArticleId IdType="pubmed">21976403</ArticleId></ArticleIdList></Reference><Reference><Citation>Guleria A, Phatak S, Dubey D, Kumar S, Zanwar A, Chaurasia S, Kumar U, Gupta R, Aggarwal A, Kumar D, et al. NMR-based serum metabolomics reveals reprogramming of lipid dysregulation following cyclophosphamide-based induction therapy in lupus nephritis. J Proteome Res. 2018;17(7):2440&#x2013;2448. doi: 10.1021/acs.jproteome.8b00192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.8b00192</ArticleId><ArticleId IdType="pubmed">29877087</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>